Disclosed herein compositions of polysaccharides chemically cross-linked by aromatic dialdehydes. The compositions may be in form of polymeric sheets for a variety of applications. Disclosed also nano-sized particles comprising the polysaccharide chemically cross-linked by aromatic dialdehydes. The nano-sized particles may further comprise lipids and surfactants. Intranasal delivery of the nano-sized particles enables delivery of biologically active agents into the brain. Topical and transdermal delivery of the nano-sized particles enables delivery of biologically active agents for treatment of systemic or dermatological disorders. Methods of manufacturing and uses of the compositions are also disclosed.

Disclosed herein compositions of polysaccharides chemically cross-linked by aromatic dialdehydes. The compositions may be in form of polymeric sheets for a variety of applications. Disclosed also nano-sized particles comprising the polysaccharide chemically cross-linked by aromatic dialdehydes. The nano-sized particles may further comprise lipids and surfactants. Intranasal delivery of the nano-sized particles enables delivery of biologically active agents into the brain. Topical and transdermal delivery of the nano-sized particles enables delivery of biologically active agents for treatment of systemic or dermatological disorders. Methods of manufacturing and uses of the compositions are also disclosed.

A composition having molecular iodine in combination with a polyol can be used for control and treatment of microbes and infections on biological and non-biological surfaces. Compositions have a combination of molecular iodine (I2) and an acceptable source of iodate (IO3), and a buffering acid (inorganic or organic), in combination with a polyol in an amount of 3-50% by weight. The present compositions can also have prebiotic and probiotic properties on biological surfaces and membranes for the control and treatment of infection as well as the support of growth of commensal microbes and the control of pathogenic microbes.

A composition having molecular iodine in combination with a polyol can be used for control and treatment of microbes and infections on biological and non-biological surfaces. Compositions have a combination of molecular iodine (I2) and an acceptable source of iodate (IO3), and a buffering acid (inorganic or organic), in combination with a polyol in an amount of 3-50% by weight. The present compositions can also have prebiotic and probiotic properties on biological surfaces and membranes for the control and treatment of infection as well as the support of growth of commensal microbes and the control of pathogenic microbes.

A composition having molecular iodine in combination with a polyol can be used for control and treatment of microbes and infections on biological and non-biological surfaces. Compositions have a combination of molecular iodine (I2) and an acceptable source of iodate (IO3), and a buffering acid (inorganic or organic), in combination with a polyol in an amount of 3-50% by weight. The present compositions can also have prebiotic and probiotic properties on biological surfaces and membranes for the control and treatment of infection as well as the support of growth of commensal microbes and the control of pathogenic microbes.

The present patent application relates a process for the production of compressed tablets using specific coated particles, wherein the coating (system) comprises at least one wax and/or at least one fat. Furthermore it relates to compressed (compacted) tablets and as well as to specific coated particles.

The present patent application relates a process for the production of compressed tablets using specific coated particles, wherein the coating (system) comprises at least one wax and/or at least one fat. Furthermore it relates to compressed (compacted) tablets and as well as to specific coated particles.

Disclosed herein are prenatal dosage forms formulated for different stages of the pregnancy cycle. Also disclosed are methods of administering prenatal dosage forms to a prenatal, pregnant or lactating woman. Further disclosed are kits including prenatal dosage forms.

Disclosed herein are prenatal dosage forms formulated for different stages of the pregnancy cycle. Also disclosed are methods of administering prenatal dosage forms to a prenatal, pregnant or lactating woman. Further disclosed are kits including prenatal dosage forms.

Disclosed herein is pharmaceutical compositions of Compound 1, and/or the hydroquinone form thereof, and methods useful for treating or suppressing a disease or disorder such as an α-synucleinpathy, a tauopathy, an autistic spectrum disorder, a pervasive developmental disorder, a liver disease, and liver damage in a subject using such pharmaceutical compositions.